Main Menu

Clinical Pharmacology Adaptive Therapy Group

Professor Banerji's team aims to study re-wiring of signal transduction to understand and overcome mechanisms of drug resistance and, in addition, to understand exploit cancer evolution using pharmacological tools.

Team leader

Professor Udai Banerji

Professor Udai Banerji

Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is Deputy Director of the Drug Development Unit at The ICR and Royal Marsden, and also heads the Clinical Pharmacodynamics Biomarker Group and the Clinical Pharmacology-Adaptive Therapy Group.

T 0208 661 3984

Team Members

Dr Alexandros Georgiou

Clinical Research Fellow

Dr Lisa Pickard

Higher Scientific Officer

Adam Stewart

Higher Scientific Officer

Parames Thavasu

Scientific Officer
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.